Clinical trials
Phase 2 Neuroinflammatory Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Enrolling by invitation | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aaron Ritter, MD | 1 |
| Boston University Charles River Campus | 1 |
| Huntington Medical Research Institutes | 1 |
| Johns Hopkins University | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
| New York State Psychiatric Institute | 1 |
| Reveal Pharmaceuticals Inc. | 1 |
| Summit Hyperbarics and Wellness | 1 |
| Sundance Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroinflammatory Diseases | 14 |
| Alzheimer Disease | 3 |
| Multiple Sclerosis | 3 |
| Brain Edema | 1 |
| Brain Injuries, Traumatic | 1 |
| Brain Neoplasms | 1 |
| COVID-19 | 1 |
| Central Nervous System Neoplasms | 1 |
| Cerebral Hemorrhage | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.